LUNG CANCER (SCLC)
Clinical trials for LUNG CANCER (SCLC) explained in plain language.
Never miss a new study
Get alerted when new LUNG CANCER (SCLC) trials appear
Sign up with your email to follow new studies for LUNG CANCER (SCLC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for tough lung cancer: triple combo targets liver tumors
Disease control Not yet recruitingThis study tests whether adding radiotherapy to standard immunotherapy and chemotherapy can help people with advanced small cell lung cancer that has spread to the liver. About 30 adults aged 18-75 whose cancer worsened after prior treatments will receive the combination. The goa…
Matched conditions: LUNG CANCER (SCLC)
Phase: PHASE2 • Sponsor: Sichuan University • Aim: Disease control
Last updated May 26, 2026 08:21 UTC
-
New scan could reveal who responds to immunotherapy
Diagnosis Not yet recruitingThis study tests a special PET scan that uses a radioactive probe to detect PD-L1, a protein on tumor cells, in people with lung cancer, melanoma, or other solid tumors. The goal is to see if this scan can predict who will benefit from immunotherapy. About 40 adults aged 18-75 wh…
Matched conditions: LUNG CANCER (SCLC)
Sponsor: Peking University Cancer Hospital & Institute • Aim: Diagnosis
Last updated May 26, 2026 08:19 UTC